Efficacy of ipragliflozin on glucose metabolism

Efficacy of ipragliflozin on glucose metabolism - Efficacy of ipragliflozin on glucose metabolism

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013921

Enrollment

Registered

2014-05-16

Start date

2014-05-16

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes mellitus

Interventions

treatment with ipragliflozin

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: type 2 diabetic patients with poor glycemic control

Exclusion criteria

Exclusion criteria: - severe hepatic, renal, and/or cardiac diseae - contraindication to ipragliflozin - pregnant or breast-feeding females

Design outcomes

Primary

Measure	Time frame
Change of glucose metabolism assessed by a 75-g oral glucose tolerance test	—

Countries

Japan

Contacts

Public ContactMitsuyoshi Takahara

Osaka University Graduate School of Medicine Dept of Metabolic Medicine

takahara@endmet.med.osaka-u.ac.jp06-6879-3743

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026